1Q25 Earnings Summary May 1, 2025 1 1st Quarter 2025 Earnings Summary Conference Call Friday, May 2, 2025 10:00 a.m. ET Webcast Link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=J4Z1igJk Participant dial-in numbers: Domestic callers: (877) 402-8037 International callers: (201) 378-4913 2 General Disclosure Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exch ...

Radian Group (RDN) reported first-quarter 2025 adjusted operating income of 99 cents per share, which beat the Zacks Consensus Estimate by 4.2%. The bottom line decreased 3.9% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)The results reflected muted premiums, lower persistence, higher default loans and higher expenses.Quarter in Detail  Operating revenues remained flat year over year at $306 million and missed the Zacks Consensus Estimate by 6.4%.Net premiums earne ...

Financial Performance - Targa Resources, Inc. reported revenue of $4.56 billion for the quarter ended March 2025, which is unchanged compared to the same period last year [1] - Earnings per share (EPS) for the quarter was $0.91, down from $1.22 in the year-ago quarter [1] - The reported revenue fell short of the Zacks Consensus Estimate of $5.31 billion, resulting in a surprise of -14.12% [1] - The company experienced an EPS surprise of -55.39%, with the consensus EPS estimate being $2.04 [1] Stock Performance - Targa Resources shares have returned -16.9% over the past month, compared to the Zacks S&P 500 composite's -0.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3] Key Metrics - Gathering and Processing - NGL sales per day were 570.2 million barrels of oil, below the two-analyst average estimate of 577.97 million barrels [4] - Gathering and Processing - Gross NGL production (Coastal) was 32.7 million barrels of oil per day, exceeding the two-analyst average estimate of 31.89 million barrels [4] - Gathering and Processing - Condensate sales per day were 18.1 million barrels of oil, lower than the estimated 20.5 million barrels [4] - Logistics and Marketing - NGL sales were 1186.4 million barrels of oil per day, slightly below the estimated 1198.95 million barrels [4] - Logistics and Marketing - Export volumes were 447.7 million barrels of oil per day, compared to the estimated 455.64 million barrels [4] - Gathering and Processing - Total Plant natural gas inlet volumes were 7526.3 million cubic feet per day, below the estimated 7667.93 million cubic feet [4] - Average realized prices for Condensate were $72.32, slightly below the estimated $73.57 [4] - Average realized prices for Natural gas were $2.24, compared to the estimated $2.45 [4] - Average realized prices for NGL were $0.50, slightly below the estimated $0.51 [4]

Core Viewpoint - Rayonier, Inc. reported a pro-forma net loss of 2 cents per share for Q1 2025, missing the Zacks Consensus Estimate of 8 cents and down from a net income of 1 cent per share in the prior year [1] Financial Performance - Total revenues for Q1 2025 were $82.9 million, falling short of the Zacks Consensus Estimate of $157 million and representing a 27.1% decrease year-over-year [2] - Adjusted EBITDA for the quarter was $27.1 million, down from $44.6 million in the prior-year period [2] Segment Performance - Southern Timber segment reported pro-forma operating income of $10.1 million, a decline of 56.1% from the prior-year quarter due to lower net stumpage realizations and higher costs [4] - Pacific Northwest Timber segment showed pro-forma operating income of $0.7 million, recovering from a loss of $4.4 million a year ago, attributed to lower costs and higher net stumpage realizations [5] - Real Estate segment incurred a pro-forma operating loss of $1 million compared to a $0.1 million loss in the previous year, driven by fewer acres sold [6] Balance Sheet - Rayonier ended Q1 2025 with $216.2 million in cash and cash equivalents, down from $303.1 million as of December 31, 2024 [7] Future Outlook - For Q2 2025, management anticipates net income attributable to Rayonier to be between $3 million and $8 million, with pro forma EPS expected to range from 1 cent to 4 cents [8] - Full-year net income guidance has been revised to $424 million to $458 million, significantly up from the previous guidance of $79 million to $100 million, reflecting anticipated gains from the sale of the New Zealand joint venture [9] - Adjusted EBITDA for the full year is projected to be between $215 million and $235 million, down from prior guidance of $270 million to $300 million [10]

IDEXX Q1 2024 Earnings Highlights (NASDAQ: IDXX) IDEXX Q1 2025 Earnings Highlights (NASDAQ: IDXX) | Revenue | | | Operating | | | Diluted | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | Profit | | | Earnings Per Share | | | | | $998M | | | $317M | | | $2.96 | | | | | Reported growth: | +4% | 31.7% | of Revenue | | | | | | | | | | | | | | Reported growth: | | +5% | | | Organic growth: | +5% | YoY change in basis points: | | | | | | | | | CAG Diagnostics Recurring | | Reported | ...

Core Insights - Broadridge Financial Solutions, Inc. reported mixed third-quarter fiscal 2025 results, with adjusted earnings per share of $2.44 beating the Zacks Consensus Estimate by 2.1% and increasing 9.4% year over year, while total revenues of $1.81 billion missed the consensus mark by 2.5% but were up 5% year over year [1] Financial Performance - Recurring revenues reached $1.2 billion, reflecting a 7% year-over-year increase on a reported basis and an 8% increase on a constant currency basis [1] - Revenues in the Investor Communication Solutions segment increased 4% year over year to $1.35 billion, below the estimate of $1.4 billion, while the Global Technology and Operations segment's revenues amounted to $464 million, exceeding the estimate of $452.3 million and increasing 9% year over year [3] - Adjusted operating income was $405.2 million, up 9.7% from the previous year, with an adjusted operating income margin of 22.4%, which is an increase of 100 basis points year over year [4] Cash Flow and Capital Expenditures - The company generated $360.7 million in cash from operating activities, with capital expenditures of $11.5 million during the quarter, and paid out $103 million in dividends [5] Future Guidance - For fiscal 2025, the company expects recurring revenue growth of 6-8%, adjusted earnings per share growth of 8-12%, and an adjusted operating income margin around 20% [6] Stock Performance - The company's stock has gained 26.1% over the past year, compared to a 25.8% increase in the industry and an 11.5% growth in the Zacks S&P 500 Composite [2]

Core Viewpoint - Church & Dwight Co., Inc. (CHD) reported mixed first-quarter 2025 results, with adjusted earnings per share (EPS) beating estimates but net sales missing expectations, reflecting a challenging operating environment [1][2]. Financial Performance - Adjusted EPS for the quarter was 91 cents, surpassing the Zacks Consensus Estimate of 89 cents and the company's guidance of 90 cents, although it represented a 5.2% decline year over year [1]. - Net sales totaled $1,467.1 million, down 2.4% year over year, missing the Zacks Consensus Estimate of $1,511 million and the company's guidance for a nearly 1% increase [3]. - Organic sales decreased by 1.2%, driven by a 1.4% drop in volumes, partially offset by a 0.2% increase in pricing and mix [4]. Segment Analysis - **Consumer Domestic**: Net sales fell 3% to $1,129.8 million, with organic sales down 3% due to a 3.1% volume drop [6]. - **Consumer International**: Net sales increased by 2.7% to $261.9 million, with organic sales climbing 5.8%, driven by a 5.9% volume growth [7]. - **Specialty Products**: Sales declined 9.3% to $75.4 million, although organic sales grew by 3.2% [8]. Cost and Margin Insights - Gross margin contracted by 70 basis points to 45%, with adjusted gross margin at 45.1%, down 60 basis points year over year due to higher manufacturing costs [5]. - Marketing expenses decreased by $15.4 million year over year to $136.6 million, while adjusted selling, general, and administrative (SG&A) expenses increased by 40 basis points to 15.2% of net sales [5]. Future Outlook - For 2025, CHD projects organic sales growth of around 0-2%, down from a previous estimate of 3-4%, reflecting ongoing macroeconomic challenges [15]. - Adjusted EPS growth is now expected to be 0-2%, a reduction from the earlier guidance of 7-8% [17]. - The company anticipates a decline in organic sales of 2% for the second quarter, with adjusted EPS projected at 85 cents, a 9% decrease from the prior year [18].

Core Viewpoint - OPKO Health, Inc. reported a narrower loss per share of 10 cents in Q1 2025 compared to a loss of 12 cents in the same period last year, but this was wider than the Zacks Consensus Estimate of a loss of 6 cents per share [1][13] Revenue Summary - OPKO Health's total revenues for Q1 2025 were $149.9 million, reflecting a 13.7% decrease year over year and missing the Zacks Consensus Estimate by 8.9% [1][2] - Revenues from the Diagnostics segment amounted to $102.8 million, down 18.9% year over year, primarily due to lower clinical test volume [4] - In the Pharmaceuticals segment, revenues from products declined 8.7% year over year to $34.8 million, impacted by unfavorable foreign currency exchange and decreased Rayaldee sales [5] - Revenues from the transfer of intellectual property increased by 41.4% year over year to $12.3 million, driven by a significant rise in BARDA contract revenues [6] Margin Analysis - Gross profit increased by 1.4% year over year to $42.6 million, with gross margin expanding by 424 basis points to 28.4% [7] - Selling, general and administrative expenses decreased by 15.8% year over year to $59.1 million, while research and development expenses rose by 40.6% to $30.8 million [7][8] Financial Position - OPKO Health ended Q1 2025 with cash and cash equivalents of $436 million, slightly up from $431.9 million at the end of 2024 [9] Guidance - The company revised its 2025 revenue outlook to a range of $675 million to $685 million, down from a previous range of $675 million to $700 million [11] - Product sales are expected to be between $165 million and $175 million, while other revenues are now projected to be between $75 million and $85 million [12] Recent Developments - OPKO Health signed an agreement with Labcorp to sell oncology-related clinical testing assets and entered a collaboration with Entera Bio for an oral GLP-1/glucagon tablet candidate [15] - ModeX Therapeutics Inc., a subsidiary of OPKO, is advancing its immuno-oncology and immunology portfolio with four clinical candidates [15]

Core Points - Huntington Ingalls Industries, Inc. (HII) reported first-quarter 2025 earnings of $3.79 per share, a decline of 2.1% from $3.87 in the prior-year quarter, but exceeded the Zacks Consensus Estimate of $2.90 by 30.7% [1] - Total revenues for the quarter were $2.73 billion, missing the Zacks Consensus Estimate of $2.79 billion by 2% and declining 2.5% from $2.81 billion in the year-ago quarter due to lower sales volume across all business segments [2] Operational Performance - Segmental operating income was $171 million, slightly up from $170 million in the first quarter of 2024, with an operating margin expansion of 19 basis points to 6.3% [3] - The increase in operating income was mainly driven by better performance in the Newport News Shipbuilding and Mission Technologies units [3] Orders and Backlog - HII received orders worth $2.1 billion in the first quarter of 2025, resulting in a total backlog of $48 billion as of March 31, 2025, down from $48.7 billion as of December 31, 2024 [4] Segmental Performance - Newport News Shipbuilding: Revenues totaled $1.40 billion, down 2.6% year over year, with operating income of $85 million, up 3.7% year over year due to contract incentives from the Virginia-class submarine program [5] - Ingalls Shipbuilding: Revenues were $637 million, down 2.7% year over year, with operating earnings of $46 million, down 23.3% year over year due to lower performance in amphibious assault ships [6] - Mission Technologies: Revenues totaled $735 million, down 2% year over year, with operating income increasing 42.9% year over year to $40 million, driven by higher performance in cyber, electronic warfare & space, and uncrewed systems [6][7] Financial Update - Cash and cash equivalents as of March 31, 2025, were $167 million, significantly down from $831 million as of December 31, 2024 [8] - Long-term debt remained at $2.70 billion as of March 31, 2025, consistent with the end of 2024 [8] - Cash used in operating activities was $395 million compared to $202 million a year ago [8] - Free cash outflow was $462 million in the first quarter of 2025, higher than $274 million in the prior-year period [9] 2025 Guidance - HII reaffirmed its 2025 guidance, expecting shipbuilding revenues in the range of $8.9-$9.1 billion and Mission Technologies revenues in the range of $2.9-$3.1 billion [10] - The company projects free cash flow to be between $300-$500 million [10]

Core Insights - Aptiv PLC reported better-than-expected first-quarter 2025 results with adjusted earnings of $1.69 per share, beating the Zacks Consensus Estimate by 9% and increasing 45.7% year over year [1] - Revenues for the quarter were $4.80 billion, surpassing the Zacks Consensus Estimate by 0.4% but decreasing 1.6% year over year [1] Revenue Performance - Adjusted revenues declined 1% year over year, with specific declines of 4% in Europe, 2% in North America, and 3% in South America, while Asia saw a growth of 5%, including a 2% increase in China [1] - The Electrical Distribution Systems and Engineered Components Group reported revenues of $2 billion and $1.6 billion, declining 3% and 1% year over year, respectively [2] - The Advanced Safety and User Experience segment's revenues remained flat at $1.4 billion year over year [2] Operating Income and Margins - Adjusted operating income was $572 million, up 5.2% from the previous year, with an adjusted operating income margin of 11.9%, an increase of 80 basis points year over year [2] Cash Flow and Debt - At the end of the quarter, Aptiv had cash and cash equivalents of $1.1 billion, down from $1.6 billion in the previous quarter, while long-term debt decreased from $7.8 billion to $7.6 billion [3] - The company generated $273 million in cash from operating activities, compared to $244 million in the first quarter of 2024 [3] Future Outlook - For Q2 2025, Aptiv expects revenues between $4.92 billion and $5.12 billion, and adjusted EPS between $1.7 and $1.9, both higher than current Zacks Consensus Estimates [4] - For the full year 2025, revenues are expected to be between $19.6 billion and $20.4 billion, with adjusted EPS between $7 and $7.6, also above current estimates [5] - The adjusted operating income margin for 2025 is anticipated between 11.9% and 12.3%, with capital expenditure expected to be $880 million [5]